Imricor Medical Systems is forecast to grow earnings and revenue by 42.5% and 88.5% per annum respectively while EPS is expected to grow by 57.3% per annum.
Key information
42.5%
Earnings growth rate
57.3%
EPS growth rate
Medical Equipment earnings growth
16.1%
Revenue growth rate
88.5%
Future return on equity
n/a
Analyst coverage
Low
Last updated
11 Nov 2024
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
CHIA:IMR - Analysts future estimates and past financials data (USD Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2026
20
-6
-10
-9
1
12/31/2025
9
-11
-14
-13
1
12/31/2024
4
-16
-16
-15
1
6/30/2024
1
-20
-15
-15
N/A
3/31/2024
1
-21
-14
-14
N/A
12/31/2023
1
-23
-13
-13
N/A
9/30/2023
1
-20
-14
-14
N/A
6/30/2023
0
-17
-14
-14
N/A
3/31/2023
1
-17
-16
-15
N/A
12/31/2022
1
-17
-17
-17
N/A
9/30/2022
1
-18
-17
-17
N/A
6/30/2022
1
-20
-17
-17
N/A
3/31/2022
1
-20
-18
-17
N/A
12/31/2021
1
-20
-18
-17
N/A
9/30/2021
1
-18
-17
-16
N/A
6/30/2021
1
-17
-16
-15
N/A
3/31/2021
1
-15
-15
-14
N/A
12/31/2020
1
-12
-13
-12
N/A
9/30/2020
1
-13
-12
-11
N/A
6/30/2020
1
-14
-10
-9
N/A
3/31/2020
1
-14
-9
-8
N/A
12/31/2019
1
-13
-7
-7
N/A
9/30/2019
1
-11
-6
-6
N/A
6/30/2019
0
-8
-6
-5
N/A
3/31/2019
1
-7
-5
-5
N/A
12/31/2018
1
-5
-5
-5
N/A
12/31/2017
0
-5
N/A
-4
N/A
12/31/2016
1
-4
N/A
-3
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IMR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IMR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IMR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IMR's revenue (88.5% per year) is forecast to grow faster than the Australian market (5.7% per year).
High Growth Revenue: IMR's revenue (88.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IMR's Return on Equity is forecast to be high in 3 years time